A Stitch in Time: Taiwan and Japan Join Hands in Providing Critical Care
HSINCHU, Taiwan Japan has donated five batches of the AZ COVID-19 vaccine to Taiwan, and Taiwan has reciprocated by providing treatment at NTHU’s Boron Neutron Capture Therapy Center (BNCTC) for a...
View ArticleCanon Medical Signals Its Support for a Multicenter Ultrasound Liver...
OTAWARA, Tochigi Prefecture, Japan Canon Medical announced today its support for the iLEAD (innovative Liver, Elasticity, Attenuation and Dispersion) study, an international multicenter study aiming...
View ArticleEnzychem to Partner with Zydus Cadila to Manufacture COVID-19 Plasmid DNA...
SEOUL, South Korea & AHMEDABAD, India & ENGLEWOOD CLIFFS, N.J. Enzychem Lifesciences (KOSDAQ: 183490) and Cadila Healthcare Ltd, a part of the Zydus Group, today announced that they have...
View ArticleCanon Medical Introduces Super-Resolution Deep-Learning Reconstruction for...
OTAWARA, Japan Canon Medical is breaking ground once again with the introduction of Precise IQ Engine (PIQE) DLR and SilverBeam filter in the latest version of the Aquilion ONE / PRISM edition....
View ArticleEuropean Commission Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA®...
KENILWORTH, N.J. & TOKYO Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the European Commission has approved the combination of KEYTRUDA,...
View ArticleCanon Medical Launches New, Advanced Productivity 1.5T MRI System to...
OTAWARA, Japan Canon Medical today unveiled the Vantage Fortian – a new, advanced productivity, open bore 1.5T MRI system – at RSNA 2021. The new system features innovative workflow solutions, image...
View Article武田在美国血液学会(ASH)第63届年会上发布可促进血液病和肿瘤患者治疗的新研究成果
马萨诸塞州剑桥和日本大阪 武田药品工业株式会社(Takeda Pharmaceutical Company Limited,...
View Article武田薬品が第63回米国血液学会(ASH)年次総会で血液疾患およびオンコロジーの領域における患者治療を前進させる新たな研究を発表
米マサチューセッツ州ケンブリッジ & 大阪...
View ArticleENHERTU® Additional Analyses Further Reinforce Groundbreaking Efficacy in...
TOKYO & MUNICH & BASKING RIDGE, N.J. New results from the DESTINY-Breast03 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated higher progression-free survival (PFS) and...
View Article凌腾医药宣布,卡妥索双抗用于介苗治疗失败的非肌层浸润性膀胱癌的1期临床试验已完成首例患者给药
中国广州 (美国商业资讯)–凌腾医药(LintonPharm Co., Ltd.)是一家总部位于中国的临床阶段生物制药公司,专注于开发用于癌症免疫疗法的T细胞衔接双特异性抗体。公司今天宣布,单克隆双特异性抗体卡妥索双抗(catumaxomab)用于卡介苗(BCG)治疗失败的非肌层浸润性膀胱癌(Non-Muscle Invasive Bladder Cancer,...
View Articleアレフ・ファームズとWACKERが培養肉の大規模生産に使用されるタンパク質のオープンなサプライチェーン・ソリューションを開発
ミュンヘン & イスラエル・レホボト (ビジネスワイヤ) —...
View ArticleEurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through...
LUXEMBOURG Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic...
View ArticleBeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment...
View ArticleBeiGene Presents Updated Safety and Efficacy Findings on BRUKINSA...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines, today presented...
View ArticleValemetostat Pivotal Data Shows Promising Response Rates in Patients with...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that valemetostat, a potential first-in-class dual inhibitor of EZH1 and EZH2,...
View ArticleBeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment...
View ArticleNumab and 3SBio’s Sunshine Guojian Expand Partnership to Develop Novel T Cell...
WÄDENSWIL, Switzerland, SHENYANG, China, & SHANGHAI Numab Therapeutics AG (Numab) and 3SBio Inc. (“3SBio”, HKEX:1530) announced today that 3SBio’s subsidiary Sunshine Guojian Pharmaceutical...
View ArticleProvectus Algae Moves Sustainable Synthetic Biology Biomanufacturing Platform...
NOOSAVILLE, Australia Provectus Algae (Provectus), an Australian synthetic biology company specializing in biomanufacturing to produce specialty ingredients for a wide array of industries and...
View ArticleBostonGene and NEC Announce Global Partnership
TOKYO & WALTHAM, Mass. BostonGene Corporation and NEC Corporation (NEC; TSE: 6701) today announced a strategic global partnership agreement that will enable the companies to offer BostonGene...
View Article新研究显示,Masimo SedLine®脑功能监护仪或有助于及早识别有术后谵妄风险的患者
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布了在《麻醉与镇痛》(Anesthesia & Analgesia)上发表的一项前瞻性研究的结果,该研究中,Claudia Spies博士及其同事调查了使用Masimo...
View Article